PCBP2_HUMAN - dbPTM
PCBP2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID PCBP2_HUMAN
UniProt AC Q15366
Protein Name Poly(rC)-binding protein 2
Gene Name PCBP2
Organism Homo sapiens (Human).
Sequence Length 365
Subcellular Localization Nucleus . Cytoplasm . Loosely bound in the nucleus. May shuttle between the nucleus and the cytoplasm.
Protein Description Single-stranded nucleic acid binding protein that binds preferentially to oligo dC. Major cellular poly(rC)-binding protein. Binds also poly(rU). Negatively regulates cellular antiviral responses mediated by MAVS signaling. [PubMed: 19881509 It acts as an adapter between MAVS and the E3 ubiquitin ligase ITCH, therefore triggering MAVS ubiquitination and degradation]
Protein Sequence MDTGVIEGGLNVTLTIRLLMHGKEVGSIIGKKGESVKKMREESGARINISEGNCPERIITLAGPTNAIFKAFAMIIDKLEEDISSSMTNSTAASRPPVTLRLVVPASQCGSLIGKGGCKIKEIRESTGAQVQVAGDMLPNSTERAITIAGIPQSIIECVKQICVVMLETLSQSPPKGVTIPYRPKPSSSPVIFAGGQDRYSTGSDSASFPHTTPSMCLNPDLEGPPLEAYTIQGQYAIPQPDLTKLHQLAMQQSHFPMTHGNTGFSGIESSSPEVKGYWGLDASAQTTSHELTIPNDLIGCIIGRQGAKINEIRQMSGAQIKIANPVEGSTDRQVTITGSAASISLAQYLINVRLSSETGGMGSS
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
3Phosphorylation-----MDTGVIEGGL
-----CCCCCCCCCE
31.8628387310
13PhosphorylationIEGGLNVTLTIRLLM
CCCCEEEEEEEEHHH
19.6728387310
15PhosphorylationGGLNVTLTIRLLMHG
CCEEEEEEEEHHHCC
8.4920068231
23AcetylationIRLLMHGKEVGSIIG
EEHHHCCHHHHHHHC
34.2521680723
23SumoylationIRLLMHGKEVGSIIG
EEHHHCCHHHHHHHC
34.25-
23UbiquitinationIRLLMHGKEVGSIIG
EEHHHCCHHHHHHHC
34.2521890473
23SumoylationIRLLMHGKEVGSIIG
EEHHHCCHHHHHHHC
34.25-
23UbiquitinationIRLLMHGKEVGSIIG
EEHHHCCHHHHHHHC
34.2521890473
23UbiquitinationIRLLMHGKEVGSIIG
EEHHHCCHHHHHHHC
34.2521890473
23UbiquitinationIRLLMHGKEVGSIIG
EEHHHCCHHHHHHHC
34.2521890473
23UbiquitinationIRLLMHGKEVGSIIG
EEHHHCCHHHHHHHC
34.2521890473
23UbiquitinationIRLLMHGKEVGSIIG
EEHHHCCHHHHHHHC
34.2521890473
23UbiquitinationIRLLMHGKEVGSIIG
EEHHHCCHHHHHHHC
34.2521890473
27PhosphorylationMHGKEVGSIIGKKGE
HCCHHHHHHHCCCCH
19.0628387310
31AcetylationEVGSIIGKKGESVKK
HHHHHHCCCCHHHHH
47.3923749302
31SumoylationEVGSIIGKKGESVKK
HHHHHHCCCCHHHHH
47.39-
31UbiquitinationEVGSIIGKKGESVKK
HHHHHHCCCCHHHHH
47.3921906983
31SumoylationEVGSIIGKKGESVKK
HHHHHHCCCCHHHHH
47.39-
31UbiquitinationEVGSIIGKKGESVKK
HHHHHHCCCCHHHHH
47.3921890473
31UbiquitinationEVGSIIGKKGESVKK
HHHHHHCCCCHHHHH
47.3921890473
31UbiquitinationEVGSIIGKKGESVKK
HHHHHHCCCCHHHHH
47.3921890473
31UbiquitinationEVGSIIGKKGESVKK
HHHHHHCCCCHHHHH
47.3921890473
31UbiquitinationEVGSIIGKKGESVKK
HHHHHHCCCCHHHHH
47.3921890473
31UbiquitinationEVGSIIGKKGESVKK
HHHHHHCCCCHHHHH
47.3921890473
50PhosphorylationSGARINISEGNCPER
HCCCEEECCCCCCCC
34.6621815630
54S-nitrosocysteineINISEGNCPERIITL
EEECCCCCCCCEEEE
5.64-
54GlutathionylationINISEGNCPERIITL
EEECCCCCCCCEEEE
5.6422555962
54S-nitrosylationINISEGNCPERIITL
EEECCCCCCCCEEEE
5.6419483679
54S-palmitoylationINISEGNCPERIITL
EEECCCCCCCCEEEE
5.6429575903
60PhosphorylationNCPERIITLAGPTNA
CCCCCEEEECCHHHH
14.2622210691
70AcetylationGPTNAIFKAFAMIID
CHHHHHHHHHHHHHH
36.1669191
74SulfoxidationAIFKAFAMIIDKLEE
HHHHHHHHHHHHHHH
1.9230846556
86PhosphorylationLEEDISSSMTNSTAA
HHHHHHHHCCCCCCC
23.8824719451
87SulfoxidationEEDISSSMTNSTAAS
HHHHHHHCCCCCCCC
4.4330846556
88PhosphorylationEDISSSMTNSTAASR
HHHHHHCCCCCCCCC
28.1528555341
90PhosphorylationISSSMTNSTAASRPP
HHHHCCCCCCCCCCC
15.4028555341
91PhosphorylationSSSMTNSTAASRPPV
HHHCCCCCCCCCCCE
28.4522210691
94PhosphorylationMTNSTAASRPPVTLR
CCCCCCCCCCCEEEE
42.7422210691
99PhosphorylationAASRPPVTLRLVVPA
CCCCCCEEEEEEEEH
16.37-
107PhosphorylationLRLVVPASQCGSLIG
EEEEEEHHHHHHHHC
21.6723898821
109S-nitrosocysteineLVVPASQCGSLIGKG
EEEEHHHHHHHHCCC
3.56-
109GlutathionylationLVVPASQCGSLIGKG
EEEEHHHHHHHHCCC
3.5622555962
109S-nitrosylationLVVPASQCGSLIGKG
EEEEHHHHHHHHCCC
3.5619483679
109S-palmitoylationLVVPASQCGSLIGKG
EEEEHHHHHHHHCCC
3.5629575903
111PhosphorylationVPASQCGSLIGKGGC
EEHHHHHHHHCCCCC
25.1725159151
115SumoylationQCGSLIGKGGCKIKE
HHHHHHCCCCCEEEH
45.17-
115UbiquitinationQCGSLIGKGGCKIKE
HHHHHHCCCCCEEEH
45.17-
115SumoylationQCGSLIGKGGCKIKE
HHHHHHCCCCCEEEH
45.1728112733
115UbiquitinationQCGSLIGKGGCKIKE
HHHHHHCCCCCEEEH
45.1721890473
115UbiquitinationQCGSLIGKGGCKIKE
HHHHHHCCCCCEEEH
45.1721890473
115AcetylationQCGSLIGKGGCKIKE
HHHHHHCCCCCEEEH
45.1725953088
115MalonylationQCGSLIGKGGCKIKE
HHHHHHCCCCCEEEH
45.1726320211
115UbiquitinationQCGSLIGKGGCKIKE
HHHHHHCCCCCEEEH
45.1721890473
115UbiquitinationQCGSLIGKGGCKIKE
HHHHHHCCCCCEEEH
45.1721890473
115UbiquitinationQCGSLIGKGGCKIKE
HHHHHHCCCCCEEEH
45.1721890473
115UbiquitinationQCGSLIGKGGCKIKE
HHHHHHCCCCCEEEH
45.1721890473
119UbiquitinationLIGKGGCKIKEIRES
HHCCCCCEEEHHHHH
61.15-
126PhosphorylationKIKEIRESTGAQVQV
EEEHHHHHHCCEEEE
23.4625627689
127PhosphorylationIKEIRESTGAQVQVA
EEHHHHHHCCEEEEE
31.6125159151
154PhosphorylationTIAGIPQSIIECVKQ
HHCCCCHHHHHHHHH
21.8521712546
158S-nitrosocysteineIPQSIIECVKQICVV
CCHHHHHHHHHHHHH
3.06-
158GlutathionylationIPQSIIECVKQICVV
CCHHHHHHHHHHHHH
3.0622555962
158S-nitrosylationIPQSIIECVKQICVV
CCHHHHHHHHHHHHH
3.0619483679
158S-palmitoylationIPQSIIECVKQICVV
CCHHHHHHHHHHHHH
3.0626865113
160UbiquitinationQSIIECVKQICVVML
HHHHHHHHHHHHHHH
45.67-
169PhosphorylationICVVMLETLSQSPPK
HHHHHHHHHCCCCCC
27.9630266825
169 (in isoform 3)Phosphorylation-27.9620068231
169 (in isoform 4)Phosphorylation-27.9620068231
169 (in isoform 6)Phosphorylation-27.9620068231
169 (in isoform 7)Phosphorylation-27.9620068231
171PhosphorylationVVMLETLSQSPPKGV
HHHHHHHCCCCCCCC
35.7130266825
173PhosphorylationMLETLSQSPPKGVTI
HHHHHCCCCCCCCCC
39.5329255136
175 (in isoform 3)Phosphorylation-51.8120068231
175 (in isoform 4)Phosphorylation-51.8126356563
175 (in isoform 6)Phosphorylation-51.8120068231
175 (in isoform 7)Phosphorylation-51.8126356563
178 (in isoform 3)Phosphorylation-5.6817081983
178 (in isoform 4)Phosphorylation-5.6826356563
178 (in isoform 6)Phosphorylation-5.6817081983
178 (in isoform 7)Phosphorylation-5.6826356563
179PhosphorylationQSPPKGVTIPYRPKP
CCCCCCCCCCCCCCC
25.5530278072
179 (in isoform 5)Phosphorylation-25.5526356563
179 (in isoform 8)Phosphorylation-25.5526356563
181UbiquitinationPPKGVTIPYRPKPSS
CCCCCCCCCCCCCCC
15.0921890473
182PhosphorylationPKGVTIPYRPKPSSS
CCCCCCCCCCCCCCC
35.3823927012
182 (in isoform 5)Phosphorylation-35.3826356563
182 (in isoform 8)Phosphorylation-35.3826356563
183 (in isoform 3)Phosphorylation-27.6725849741
183 (in isoform 4)Phosphorylation-27.6726356563
183 (in isoform 6)Phosphorylation-27.6725849741
183 (in isoform 7)Phosphorylation-27.6726356563
184 (in isoform 4)Phosphorylation-47.2526356563
184 (in isoform 7)Phosphorylation-47.2526356563
185AcetylationVTIPYRPKPSSSPVI
CCCCCCCCCCCCCEE
48.8323749302
185UbiquitinationVTIPYRPKPSSSPVI
CCCCCCCCCCCCCEE
48.8321890473
185 (in isoform 4)Phosphorylation-48.8326356563
185 (in isoform 7)Phosphorylation-48.8326356563
185SumoylationVTIPYRPKPSSSPVI
CCCCCCCCCCCCCEE
48.8328112733
185UbiquitinationVTIPYRPKPSSSPVI
CCCCCCCCCCCCCEE
48.8321890473
185UbiquitinationVTIPYRPKPSSSPVI
CCCCCCCCCCCCCEE
48.8321890473
187PhosphorylationIPYRPKPSSSPVIFA
CCCCCCCCCCCEEEE
49.9622167270
187 (in isoform 5)Phosphorylation-49.9626356563
187 (in isoform 8)Phosphorylation-49.9626356563
188PhosphorylationPYRPKPSSSPVIFAG
CCCCCCCCCCEEEEC
47.3829255136
188 (in isoform 5)Phosphorylation-47.3826356563
188 (in isoform 8)Phosphorylation-47.3826356563
189PhosphorylationYRPKPSSSPVIFAGG
CCCCCCCCCEEEECC
27.7619664994
189 (in isoform 5)Phosphorylation-27.7626356563
189 (in isoform 8)Phosphorylation-27.7626356563
195 (in isoform 4)Phosphorylation-24.4426356563
195 (in isoform 7)Phosphorylation-24.4426356563
196 (in isoform 4)Phosphorylation-23.8426356563
196 (in isoform 7)Phosphorylation-23.8426356563
199 (in isoform 5)Phosphorylation-21.2926356563
199 (in isoform 8)Phosphorylation-21.2926356563
200 (in isoform 5)Phosphorylation-20.9026356563
200 (in isoform 8)Phosphorylation-20.9026356563
201PhosphorylationAGGQDRYSTGSDSAS
ECCCCCCCCCCCCCC
27.4726356563
201 (in isoform 4)Phosphorylation-27.4725884760
201 (in isoform 7)Phosphorylation-27.4725884760
202PhosphorylationGGQDRYSTGSDSASF
CCCCCCCCCCCCCCC
31.6026356563
204PhosphorylationQDRYSTGSDSASFPH
CCCCCCCCCCCCCCC
28.6026356563
205 (in isoform 5)Phosphorylation-49.9525884760
205 (in isoform 8)Phosphorylation-49.9525884760
206PhosphorylationRYSTGSDSASFPHTT
CCCCCCCCCCCCCCC
27.7526356563
208PhosphorylationSTGSDSASFPHTTPS
CCCCCCCCCCCCCHH
43.1726356563
209 (in isoform 4)Phosphorylation-5.2726356563
209 (in isoform 7)Phosphorylation-5.2726356563
212PhosphorylationDSASFPHTTPSMCLN
CCCCCCCCCHHHCCC
40.4126356563
213PhosphorylationSASFPHTTPSMCLNP
CCCCCCCCHHHCCCC
15.4426356563
213 (in isoform 5)Phosphorylation-15.4426356563
213 (in isoform 8)Phosphorylation-15.4426356563
215PhosphorylationSFPHTTPSMCLNPDL
CCCCCCHHHCCCCCC
21.7526356563
230PhosphorylationEGPPLEAYTIQGQYA
CCCCCEEEEEECCCC
8.5926356563
231PhosphorylationGPPLEAYTIQGQYAI
CCCCEEEEEECCCCC
17.5526356563
231O-linked_GlycosylationGPPLEAYTIQGQYAI
CCCCEEEEEECCCCC
17.55OGP
235 (in isoform 4)Phosphorylation-14.2225627689
236PhosphorylationAYTIQGQYAIPQPDL
EEEEECCCCCCCCCH
17.2116094384
236 (in isoform 4)Phosphorylation-17.2118669648
237 (in isoform 4)Phosphorylation-10.0925849741
239 (in isoform 5)Phosphorylation-31.3225627689
240 (in isoform 5)Phosphorylation-37.7218669648
241 (in isoform 5)Phosphorylation-32.9725849741
243 (in isoform 4)Phosphorylation-6.07-
244PhosphorylationAIPQPDLTKLHQLAM
CCCCCCHHHHHHHHH
38.65-
245UbiquitinationIPQPDLTKLHQLAMQ
CCCCCHHHHHHHHHH
51.79-
247 (in isoform 5)Phosphorylation-23.36-
254PhosphorylationHQLAMQQSHFPMTHG
HHHHHHHCCCCCCCC
15.3722167270
259PhosphorylationQQSHFPMTHGNTGFS
HHCCCCCCCCCCCCC
27.2029255136
263PhosphorylationFPMTHGNTGFSGIES
CCCCCCCCCCCCCCC
44.1729255136
266PhosphorylationTHGNTGFSGIESSSP
CCCCCCCCCCCCCCC
39.9623401153
266 (in isoform 3)Phosphorylation-39.9625627689
266AcetylationTHGNTGFSGIESSSP
CCCCCCCCCCCCCCC
39.96-
266UbiquitinationTHGNTGFSGIESSSP
CCCCCCCCCCCCCCC
39.96-
267 (in isoform 3)Phosphorylation-25.9718669648
268 (in isoform 3)Phosphorylation-4.4925849741
270PhosphorylationTGFSGIESSSPEVKG
CCCCCCCCCCCCCCC
33.9123401153
270 (in isoform 2)Phosphorylation-33.9125627689
271PhosphorylationGFSGIESSSPEVKGY
CCCCCCCCCCCCCCE
36.8023401153
271 (in isoform 2)Phosphorylation-36.8018669648
272PhosphorylationFSGIESSSPEVKGYW
CCCCCCCCCCCCCEE
34.0729255136
272 (in isoform 2)Phosphorylation-34.0725849741
274 (in isoform 3)Phosphorylation-59.83-
275UbiquitinationIESSSPEVKGYWGLD
CCCCCCCCCCEEECC
7.0921906983
276SumoylationESSSPEVKGYWGLDA
CCCCCCCCCEEECCC
44.62-
278PhosphorylationSSPEVKGYWGLDASA
CCCCCCCEEECCCCC
7.21-
278 (in isoform 2)Phosphorylation-7.21-
279UbiquitinationSPEVKGYWGLDASAQ
CCCCCCEEECCCCCC
15.0021890473
288UbiquitinationLDASAQTTSHELTIP
CCCCCCCEECEECCC
18.9221890473
289PhosphorylationDASAQTTSHELTIPN
CCCCCCEECEECCCC
20.53-
292UbiquitinationAQTTSHELTIPNDLI
CCCEECEECCCCCHH
4.3821890473
309AcetylationIIGRQGAKINEIRQM
HHCCCCCCHHHHHHH
53.5423749302
309SumoylationIIGRQGAKINEIRQM
HHCCCCCCHHHHHHH
53.54-
309UbiquitinationIIGRQGAKINEIRQM
HHCCCCCCHHHHHHH
53.54-
309SumoylationIIGRQGAKINEIRQM
HHCCCCCCHHHHHHH
53.54-
314MethylationGAKINEIRQMSGAQI
CCCHHHHHHHCCCEE
21.70-
316SulfoxidationKINEIRQMSGAQIKI
CHHHHHHHCCCEEEE
2.6128183972
317PhosphorylationINEIRQMSGAQIKIA
HHHHHHHCCCEEEEC
23.7328857561
319UbiquitinationEIRQMSGAQIKIANP
HHHHHCCCEEEECCC
10.7121890473
322SumoylationQMSGAQIKIANPVEG
HHCCCEEEECCCCCC
24.56-
322UbiquitinationQMSGAQIKIANPVEG
HHCCCEEEECCCCCC
24.5621890473
322SumoylationQMSGAQIKIANPVEG
HHCCCEEEECCCCCC
24.5628112733
323UbiquitinationMSGAQIKIANPVEGS
HCCCEEEECCCCCCC
4.8421890473
323UbiquitinationMSGAQIKIANPVEGS
HCCCEEEECCCCCCC
4.8421890473
330PhosphorylationIANPVEGSTDRQVTI
ECCCCCCCCCCEEEE
17.4020873877
331PhosphorylationANPVEGSTDRQVTIT
CCCCCCCCCCEEEEE
46.1620873877
340PhosphorylationRQVTITGSAASISLA
CEEEEECCHHHHHHH
16.4120068231
345PhosphorylationTGSAASISLAQYLIN
ECCHHHHHHHHHHHH
18.3720068231
356PhosphorylationYLINVRLSSETGGMG
HHHHCCCCCCCCCCC
18.6329396449
357PhosphorylationLINVRLSSETGGMGS
HHHCCCCCCCCCCCC
43.7130108239
359PhosphorylationNVRLSSETGGMGSS-
HCCCCCCCCCCCCC-
40.7730108239
362SulfoxidationLSSETGGMGSS----
CCCCCCCCCCC----
5.0730846556
364PhosphorylationSETGGMGSS------
CCCCCCCCC------
24.7930278072
365PhosphorylationETGGMGSS-------
CCCCCCCC-------
38.2123401153

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
173SPhosphorylationKinaseERK2P28482
PSP
173SPhosphorylationKinaseERK1P27361
PSP
189SPhosphorylationKinaseERK2P28482
PSP
189SPhosphorylationKinaseERK1P27361
PSP
213TPhosphorylationKinaseERK2P28482
PSP
213TPhosphorylationKinaseERK1P27361
PSP
272SPhosphorylationKinaseERK2P28482
PSP
272SPhosphorylationKinaseERK1P27361
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of PCBP2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of PCBP2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
PCBP2_HUMANPCBP2physical
10772858
PTBP1_HUMANPTBP1physical
10772858
HNRPK_HUMANHNRNPKphysical
10772858
HNRPL_HUMANHNRNPLphysical
10772858
HNRPD_HUMANHNRNPDphysical
10373504
PABP1_HUMANPABPC1physical
10373504
ITCH_HUMANITCHphysical
19881509
MAVS_HUMANMAVSphysical
19881509
IFIH1_HUMANIFIH1physical
19881509
PPIB_HUMANPPIBphysical
22939629
SF3B2_HUMANSF3B2physical
22365833
SLU7_HUMANSLU7physical
22365833
WDR83_HUMANWDR83physical
22365833
MEP50_HUMANWDR77physical
22365833
PCBP2_HUMANPCBP2physical
22365833
NKAP_HUMANNKAPphysical
22365833
BRCA1_HUMANBRCA1physical
22431556
SNRPA_HUMANSNRPAphysical
25416956
PCBP1_HUMANPCBP1physical
23640898

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of PCBP2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-189, AND MASSSPECTROMETRY.
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-187, AND MASSSPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-173, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-272, AND MASSSPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-173 AND SER-189, ANDMASS SPECTROMETRY.
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis.";
Wang B., Malik R., Nigg E.A., Korner R.;
Anal. Chem. 80:9526-9533(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-173 AND SER-189, ANDMASS SPECTROMETRY.
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-187; SER-189 ANDSER-272, AND MASS SPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-173, AND MASSSPECTROMETRY.
"Quantitative phosphoproteome analysis using a dendrimer conjugationchemistry and tandem mass spectrometry.";
Tao W.A., Wollscheid B., O'Brien R., Eng J.K., Li X.-J.,Bodenmiller B., Watts J.D., Hood L., Aebersold R.;
Nat. Methods 2:591-598(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-236, AND MASSSPECTROMETRY.

TOP